Susanne B Haga
Associate Research Professor of Biology
Education
Ph.D., University of Maryland, Baltimore 1999
Ginsburg, G. S., and S. B. Haga. “Foundations and application of precision medicine.” In Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Foundations, 21–45, 2018. https://doi.org/10.1016/B978-0-12-812537-3.00002-0. Full Text
Haga, S. B. “Precision Medicine and Challenges in Research and Clinical Implementation.” In Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition, 717–32, 2017. https://doi.org/10.1016/B978-0-12-803506-1.00021-8. Full Text
Haga, S. B. “Overview of Policy, Ethical, and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Precision Medicine: Primary Care: Third Edition, 19–43, 2017. https://doi.org/10.1016/B978-0-12-800685-6.00005-9. Full Text
Haga, S. B. “Overview of Policy, Ethical and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Personalized Medicine, 1:392–404, 2013. https://doi.org/10.1016/B978-0-12-382227-7.00034-3. Full Text
Haga, S. B. “Genome Policy Considerations for Genomic Medicine.” In Essentials of Genomic and Personalized Medicine, 209–22, 2010. https://doi.org/10.1016/B978-0-12-374934-5.00018-0. Full Text
Haga, S. B. “From Sequence to Genomic Medicine: Genome Policy Considerations.” In Genomic and Personalized Medicine, Two-Vol Set, 387–400, 2009. https://doi.org/10.1016/B978-0-12-369420-1.00033-0. Full Text
Haga, Susanne B. “Individualizing pharmacogenomic test results in the context of the microbiome.” Per Med 17, no. 6 (November 2020): 459–68. https://doi.org/10.2217/pme-2020-0077. Full Text
Brown, Lisa, Seenae Eum, Susanne B. Haga, Jeffrey R. Strawn, and Heather Zierhut. “Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.” Pharmacopsychiatry 53, no. 4 (July 2020): 162–73. https://doi.org/10.1055/a-0975-9595. Full Text
Haga, Susanne B. “Toward digital-based interventions for medication adherence and safety.” Expert Opin Drug Saf 19, no. 6 (June 2020): 735–46. https://doi.org/10.1080/14740338.2020.1764935. Full Text
Haga, Susanne B., and Lori A. Orlando. “The enduring importance of family health history in the era of genomic medicine and risk assessment.” Per Med 17, no. 3 (May 1, 2020): 229–39. https://doi.org/10.2217/pme-2019-0091. Full Text Open Access Copy
Haga, Susanne B., Ryan Shaw, Charles Kneifel, Sarah J. Bond, and Geoffrey S. Ginsburg. “Promoting Wellness Through Mobile Health Technology in a College Student Population: Protocol Development and Pilot Study.” Jmir Res Protoc 9, no. 4 (April 3, 2020): e16474. https://doi.org/10.2196/16474. Full Text
Haga, Susanne B. “Managing Increased Accessibility to Pharmacogenomic Data.” Clin Pharmacol Ther 106, no. 5 (November 2019): 922–24. https://doi.org/10.1002/cpt.1602. Full Text
Weitzel, Kristin Wiisanen, Benjamin Q. Duong, Meghan J. Arwood, Aniwaa Owusu-Obeng, Noura S. Abul-Husn, Barbara A. Bernhardt, Brian Decker, et al. “A stepwise approach to implementing pharmacogenetic testing in the primary care setting.” Pharmacogenomics 20, no. 15 (October 2019): 1103–12. https://doi.org/10.2217/pgs-2019-0053. Full Text
Haga, Susanne B. “First Responder to Genomic Information: A Guide for Primary Care Providers.” Mol Diagn Ther 23, no. 4 (August 2019): 459–66. https://doi.org/10.1007/s40291-019-00407-z. Full Text
Villegas, Catalina, and Susanne B. Haga. “Access to Genetic Counselors in the Southern United States.” J Pers Med 9, no. 3 (July 1, 2019). https://doi.org/10.3390/jpm9030033. Full Text
Haga, Susanne B., and Yiling Liu. “Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.” Pharmacogenomics 20, no. 8 (June 2019): 581–87. https://doi.org/10.2217/pgs-2019-0006. Full Text
Pages
Selected Grants
Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations. awarded by National Institutes of Health (Investigator). 2018 to 2023
Preparing Genetic Counselors for Genomic Medicine Research awarded by National Institutes of Health (Principal Investigator). 2017 to 2022
IRES Track 1 IRTG Engaged in Dissecting and Reengineering the Regulatory Genome awarded by National Science Foundation (Associate Director). 2019 to 2022
Postdoctoral Training in Genomic Medicine Research awarded by National Institutes of Health (Co-Principal Investigator). 2017 to 2021
Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health (Principal Investigator). 2011 to 2020
VGER, The Vanderbilt Genome-Electronic Records Project awarded by Vanderbilt University Medical Center (Investigator). 2018 to 2020
IPA -Rachel Mills awarded by Durham Veterans Affairs Medical Center (Principal Investigator). 2019
Impact of Personal Genomic Testing on Primary Care Physician Knowledge and Attitudes awarded by 23andMe, Inc (Principal Investigator). 2017 to 2018
Genetic Risk Testing & Health Coaching for T2D and CHD awarded by Air Force Office of Scientific Research (Co Investigator). 2013 to 2017
Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health (Principal Investigator). 2007 to 2015